Our customers' Feedback
Search:
Perform search
Categories list

Generic Adcirca

News
Adcirca
Adcirca photo

Generic Adcirca (Tadalafil)

Cardiovascular Diseases

PackagePricePer PillSavingsOrder
20mg × 10 pills$49.95$5.00Add to cart
20mg × 20 pills$89.95$4.50$9.95Add to cart
20mg × 30 pills$119.95$4.00$29.90Add to cart
20mg × 60 pills$199.95$3.33$99.75Add to cart
20mg × 90 pills$249.95$2.78$199.60Add to cart
20mg × 120 pills$299.95$2.50$299.45Add to cart

Most popular quantity.
Apcalis Oral Jelly
$ 3.00
Apcalis® Oral Jelly
(Tadalafil 20mg)
Cialis
$ 1.30
Generic Cialis
(Tadalafil 10/20/40/60mg)
Cialis Daily
$ 1.00
Generic Cialis Daily
(Tadalafil 2.5/5mg)
Cialis Professional
$ 2.50
Generic Cialis Professional
(Tadalafil 20mg)
Cialis Soft
$ 1.45
Generic Cialis Soft
(Tadalafil 20/40mg)
Cialis Sublingual
$ 2.00
Generic Cialis Sublingual
(Tadalafil 20mg)
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Inside Lilly's 2Q16 Estimates for Its Cardiovascular Franchise - Market Realist

    Inside Lilly's 2Q16 Estimates for Its Cardiovascular FranchiseMarket RealistOther drugs for Lilly's cardiovascular franchise include Adcirca and Reopro.

  • Inside Lilly's 2Q16 Estimates for Its Oncology Franchise - Market Realist

    Inside Lilly's 2Q16 Estimates for Its Oncology FranchiseMarket RealistAdcirca is expected to report positive growth in revenues for 2Q16, while Reopro revenues are expected to have decreased during 2Q16.

  • What Lilly Expects for Revenue Growth in 2Q16 - Market Realist

    What Lilly Expects for Revenue Growth in 2Q16Market RealistOther drugs for Lilly's cardiovascular franchise include Adcirca and Reopro.

  • Adcirca (Tadalafil) - Pulmonary Hypertension News

    Adcirca (Tadalafil)Pulmonary Hypertension NewsMarketed under the name Adcirca by Eli Lilly (who later sold its exclusive commercialization rights for the drug in the U.

  • United Therapeutics Corp (UTHR) Files Form 4 Insider Selling : Martine A Rothblatt Sells 1284 Shares - Market Digest

    United Therapeutics Corp (UTHR) Files Form 4 Insider Selling : Martine A Rothblatt Sells 1284 SharesMarket DigestThe Company's key therapeutic products and product candidates include Remodulin Tyvaso (treprostinil) Adcirca (tadalafil) Remodulin Implantable System Orenitram Combination Therapy Esuberaprost and PLX Cells for the treatment of Pulmonary Arterial .

    Copyright © cheapgenerics24.com